Aegerion Pharmaceuticals, Inc.
101 Main Street
Suite 1850
Cambridge
Massachusetts
02142
United States
Tel: 617-500-7867
Fax: 908-541-1155
Website: http://www.aegerion.com/
Email: info@aegerion.com
219 articles about Aegerion Pharmaceuticals, Inc.
-
Aegerion Pharmaceuticals, Inc. to Announce Third-Quarter 2013 Financial Results on Wednesday, October 30
10/10/2013
-
Aegerion Pharmaceuticals, Inc. Grants Stock Options Under Inducement Program
10/7/2013
-
Aegerion Pharmaceuticals, Inc. Announces Presentation at the Leerink Swann and Company Rare Disease Roundtable
9/26/2013
-
Aegerion Pharmaceuticals, Inc. Observes Familial Hypercholesterolemia Awareness Day
9/24/2013
-
Aegerion Pharmaceuticals, Inc.' Lomitapide Receives Orphan Drug Designation in Japan for the Treatment of Homozygous Familial Hypercholesterolemia
9/9/2013
-
Aegerion Pharmaceuticals, Inc. Announces Presentation at the Morgan Stanley Global Healthcare Conference
9/5/2013
-
Aegerion Pharmaceuticals, Inc. Announces Presentation at the Canaccord Genuity Growth Conference
8/6/2013
-
Aegerion Pharmaceuticals, Inc. Grants Stock Options Under Inducement Program
8/5/2013
-
Aegerion Pharmaceuticals, Inc. Receives European Approval for LOJUXTA (lomitapide) to Treat Homozygous Familial Hypercholesterolemia (HoFH)
8/1/2013
-
Aegerion Pharmaceuticals, Inc. Announces Second-Quarter 2013 Financial Results
7/30/2013
-
Aegerion Pharmaceuticals, Inc. to Announce Second-Quarter 2013 Financial Results on Tuesday, July 30
7/12/2013
-
Aegerion Pharmaceuticals, Inc. Grants Stock Options Under Inducement Program
6/6/2013
-
European Medicines Agency Recommends Approval of Aegerion Pharmaceuticals, Inc.'s Pomalidomide for the Treatment of Multiple Myeloma
5/31/2013
-
Aegerion Pharmaceuticals, Inc. Announces Webcast of Investor Presentations at Upcoming Conferences
5/24/2013
-
How Marc Beer Scripted Aegerion Pharmaceuticals, Inc.'s Success Story
5/23/2013
-
Aegerion Pharmaceuticals, Inc. Announces Presentation at the Bank of America Merrill Lynch 2013 Healthcare Conference
5/3/2013
-
Aegerion Pharmaceuticals, Inc. Announces First-Quarter 2013 Financial Results
4/30/2013
-
Veristat, Inc.'s Collaboration With Aegerion Pharmaceuticals, Inc. Contributes to FDA Approval of Juxtapid
3/20/2013
-
Aegerion Pharmaceuticals, Inc. Announces Fourth-Quarter and Year-End 2012 Financial Results
3/6/2013
-
Aegerion Pharmaceuticals, Inc. Announces Presentation at the Cowen and Company 33rd Annual Health Care Conference
2/27/2013